Rachel Blank
Founder & CEO

Allara is a telehealth platform providing specialized, whole-body care for women with chronic hormonal, metabolic, and gynecological conditions such as PCOS, endometriosis, and insulin resistance. Patients receive a dedicated care team of board-certified medical providers and registered dietitians, personalized treatment plans, and comprehensive lab testing. The platform is trusted by over 120,000 women and accepts major insurance plans, with self-pay options starting at $125 per month.
Raised to date
$75MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 4 rounds





+14$30M · Undisclosed
Announced Oct 2026 · from article date
Disclosed cumulative: $72.5M
Many women experience challenges in accessing specialized care for hormonal, metabolic, and gynecological conditions, leading to delayed diagnoses and suboptimal management of conditions like PCOS, insulin resistance, and endometriosis. Traditional healthcare often lacks a holistic approach, focusing on isolated symptoms rather than addressing the underlying causes and interconnectedness of these conditions.
Allara provides a telehealth platform delivering personalized treatment plans for women with hormonal, metabolic, and gynecological conditions. The platform connects patients with a dedicated care team of board-certified specialists, including medical providers and registered dietitians, who collaborate to address the root causes of complex conditions. Patients receive comprehensive care through virtual consultations, advanced diagnostic testing, and continuous monitoring to improve symptoms and overall health outcomes. Allara's approach integrates medical expertise with nutrition and lifestyle support, offering tailored plans that encompass diet, exercise, stress management, and medication when necessary. The platform is covered by major insurance providers and offers self-pay options for those without coverage.
Allara's primary target audience is women experiencing chronic hormonal, metabolic, and gynecological conditions such as PCOS, insulin resistance, endometriosis, and thyroid disorders, who are seeking specialized, holistic care and personalized treatment plans.